BioInvent International AB logo

BINV BTA - BioInvent International AB News Story

SEK1.7 0.0  0.0%

Last Trade - 12/08/20

Sector
Healthcare
Size
Small Cap
Market Cap £268.0m
Enterprise Value £135.6m
Revenue £11.6m
Position in Universe th / 1830

BRIEF-Bioinvent to launch SEK 139 mln repair rights issue

Thu 9th July, 2020 4:33pm
July 9 (Reuters) - BioInvent International AB  BINV.ST :
    * BIOINVENT'S BOARD OF DIRECTORS RESOLVE ON A REPAIR RIGHTS
ISSUE
OF A MAXIMUM OF APPROX. SEK 139 MILLION, FOLLOWING THE
SUCCESSFULLY COMPLETED DIRECTED SHARE ISSUE OF APPROX. SEK
487 MILLION
    * BIOINVENT SAYS SUBSCRIPTION PRICE IN RIGHTS ISSUE WILL BE
SEK
1.38 PER SHARE, WHICH IS SAME AS PRICE PER SHARE PAID IN
DIRECTED SHARE ISSUE
    * BIOINVENT SAYS PROVIDED THAT RIGHTS ISSUE IS FULLY
SUBSCRIBED A
MAXIMUM NUMBER OF 100,527,062 SHARES WILL BE ISSUED AND COMPANY
WILL RECEIVE APPROXIMATELY SEK 139 MILLION BEFORE TRANSACTION
COSTS.
    * BIOINVENT SAYS NET PROCEEDS FROM RIGHTS ISSUE ARE MAINLY
INTENDED FOR PROGRESSING AND EXPANDING CLINICAL DEVELOPMENT OF
BI-1206,

Source text for Eikon:  ID:nWkr2mDr42 
Further company coverage:  BINV.ST 

 (Reporting By Johan Ahlander)
 ((johan.ahlander@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.